SGLT2 Inhibitors Promising for Heart Health in Seniors
Original Article: https://www.medscape.com/viewarticle/sglt2-inhibitors-promising-heart-health-seniors-2025a1000rlg
Background & Study OverviewA recent analysis looked at nine clinical trials conducted between 2015 and 2025 in older adults with cardiovascular disease, focusing on SGLT2 inhibitors (Dapagliflozin, Empagliflozin, and Sotagliflozin). The trials included nearly 25,000 … [Read More]

